Clinical Trial Results TV
October 24, 2012: Dr. William F. Fearon and Dr. Duane Pinto discuss: FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating
Dr. William F. Fearon and Dr. Duane Pinto discuss: FAME 2 Cost-effectiveness: A
Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in
Patients with Stable Coronary Artery Disease

St. Jude Medical:
-Grant/Research Support

NIH:
-Grant/Research Support

HeartFlow:
-Other Financial Benefit

FAME 2 was sponsored by St. Jude Medical

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
11-17-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted